Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVISTA-DOSE: IV Vitamin C and B1 for Sepsis in Uganda
NCT04999137Phase 2Unknown
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ascorbic acid in sepsis and septic shock (3 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: change in Vitamin C plasma concentration. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT04999137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04999137.